Article Versions Notes

Hlaing SP, Cao J, Lee J, Kim J, Saparbayeva A, Kwak D, Kim H, Hwang S, Yun H, Moon HR, et al. Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages. Pharmaceutics. 2022; 14(10):2118. https://doi.org/10.3390/pharmaceutics14102118

Hlaing, Shwe Phyu, Jiafu Cao, Juho Lee, Jihyun Kim, Aruzhan Saparbayeva, Dongmin Kwak, Hyunwoo Kim, Seonghwan Hwang, Hwayoung Yun, Hyung Ryong Moon, and et al. 2022. "Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages" Pharmaceutics 14, no. 10: 2118. https://doi.org/10.3390/pharmaceutics14102118

Hlaing, S. P., Cao, J., Lee, J., Kim, J., Saparbayeva, A., Kwak, D., Kim, H., Hwang, S., Yun, H., Moon, H. R., Jung, Y., & Yoo, J.-W. (2022). Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages. Pharmaceutics, 14(10), 2118. https://doi.org/10.3390/pharmaceutics14102118